- Phase 2 study explores imaging approach for interstitial lung disease
- Laverock secures funding for gene-control platform development
- Closing the immunisation gap: partnership working that delivered at scale
- LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases
- Well Pharmacy and Alzheimer’s Society launch dementia partnership
- China approves fruquintinib combination for kidney cancer
- BIOTRONIK, Charité and GHCF launch digital cardiology partnership
- Endometriosis study begins recruitment in UK hospitals
- MHRA authorises donidalorsen for hereditary angioedema prevention
- Partnership aims to expand early access to medicines
- SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer
- BioDuro and CTI Biotechnology in preclinical drug development partnership
- Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
- NICE recommends sotatercept for pulmonary arterial hypertension
- Vetter begins construction of new injectable medicines facility